New specialized division aims to improve the safe and timely delivery of medicines, medical devices, and advanced therapies worldwide
Memphis, Tennessee, 14 July 2026 – FedEx has introduced a new business division called FedEx Life Sciences to support the growing needs of the healthcare and pharmaceutical industries. The move reflects the increasing demand for faster, safer, and more reliable transportation of medical products, especially as healthcare continues to evolve with advanced treatments and personalized medicine.
Healthcare products such as vaccines, biologic medicines, medical devices, clinical trial materials, and cell and gene therapies require highly controlled transportation. Many of these products are temperature-sensitive and time-critical, making logistics one of the most important parts of the healthcare supply chain. FedEx created the new Life Sciences division to provide dedicated expertise and advanced monitoring for these specialized shipments.
The company has appointed Nick Gennari as President of Healthcare and Life Sciences. With more than three decades of experience at FedEx, he will lead the new organization and focus on strengthening services for pharmaceutical companies, healthcare providers, and research organizations around the world.
The new division combines FedEx’s global transportation network with healthcare specialists who understand the strict requirements involved in moving medical products. This includes handling temperature-controlled shipments, ensuring shipment visibility, and maintaining high standards across international supply chains. The goal is to reduce risks while helping healthcare providers receive essential products without delays.
FedEx has also invested heavily in healthcare logistics over the past few years. The company now operates six dedicated Life Sciences Centers worldwide and has strengthened its pharmaceutical network with specialized facilities and direct air connections between major healthcare manufacturing hubs. These investments are designed to improve delivery speed while maintaining product quality throughout transportation.
Advanced technology plays an important role in the new service. FedEx uses intelligent shipment monitoring systems that provide real-time visibility and can identify potential disruptions before they become serious problems. This helps customers track valuable healthcare shipments more accurately and improves the chances of on-time delivery for life-saving medicines and medical equipment.
The healthcare industry is changing rapidly as new treatments become more personalized. Cell therapies, gene therapies, biologic medicines, and precision treatments often require customized transportation methods because they are more delicate than traditional pharmaceutical products. These innovations are creating new challenges for logistics companies, including shorter delivery windows, stricter temperature controls, and complete shipment traceability.
Industry experts believe healthcare logistics will become even more important as next-generation therapies move from research laboratories to hospitals and patients. Reliable transportation networks are expected to play a critical role in ensuring these advanced treatments reach healthcare facilities safely and efficiently. Greater collaboration across airlines, logistics providers, airports, and pharmaceutical manufacturers will also help improve supply chain performance.
FedEx says the launch of its Life Sciences division reflects its long-term commitment to supporting the healthcare sector with specialized logistics services. By combining global transportation capabilities, experienced professionals, and advanced technology, the company aims to help healthcare organizations manage increasingly complex supply chains while improving access to critical medical products for patients worldwide.
